MedTrace Logo

Assessment of the Occurrence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) in Women Suffering from Endometriosis

NCT06060756 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-09-05

No results posted yet for this study

Summary

This observational study aims at establishing the proportion of patients suffering from endometriosis and for whom an Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) diagnosis is established.

The study participation will be offered to endometriosis patients displaying symptoms that may suggest an underlying OSAHS.

OSAHS diagnosis will be made according to standard of care practice and patients will be followed up to 12 months after initiating the OSAHS treatment to fill in questionnaires assessing the impact of OSAHS treatment on various endometriosis-related symptoms

Conditions

  • Endometriosis
  • Obstructive Sleep Apnea-hypopnea

Interventions

OTHER

questionnaires completion

Patients will complete the following questionnaires at 3, 6 and 12 months after start of the treatment for Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS): * Pain-related questionnaire * Endometriosis-specific questionnaire * Hospital Anxiety and Depression scale * Questionnaire McGill on Quality Of Life * Insomnia-related questionnaire

Sponsors & Collaborators

  • Elsan

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-10-31
Completion
2026-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06060756 on ClinicalTrials.gov